CIK: 1396927 - Address: C/o Orexigen Therapeutics, Inc., 12481 High Bluff Drive, Suite 160, San Diego, CA 92130
4 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret1120-5-13-22-43-63-29
S%wins1001005010010010092

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/28/07 13:26
12/26/07
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsLancaster James C JrCAOVP of CoM.d62.00030D011-74430-7-28-31-46-64
12/28/07 13:26
12/26/07
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsLancaster James C JrCAOVP of CoS.d-4514.980-3-1000D011-74430-7-28-31-46-64
11/28/07 20:55
11/26/07
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsLancaster James C JrCAOVP of CoM.d62.00030D-156-12-5-8-10-33-13-39-61
11/28/07 20:55
11/26/07
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsLancaster James C JrCAOVP of CoS.d-4314.410-3-1000D-156-12-5-8-10-33-13-39-61

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact